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Abstract
Cysteine residues in insulin degrading enzyme have been reported as non-critical for its activity. We found that converting
the twelve cysteine residues in rat insulin degrading enzyme (IDE) to serines resulted in a cysteine-free form of the enzyme
with reduced activity and decreased activation by polyanions. Mutation of each cysteine residue individually revealed
cysteine 904 as the key residue required for maximal activity and polyanion activation, although other cysteines affect
polyanion binding to a lesser extent. Based on the structure of IDE, Asn 575 was identified as a potential hydrogen bond
partner for Cys904 and mutation of this residue also reduced activity and decreased polyanion activation. The
oligomerization state of IDE did not correlate with its activity, with the dimer being the predominant form in all the samples
examined. These data suggest that there are several conformational states of the dimer that affect activity and polyanion
activation.
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Introduction
Insulin degrading enzyme (IDE), a zinc metalloprotease of the
M16A family (EC 3.4.24.56), is involved in a number of important
physiological processes. Most prominent are the enzyme’s roles in
type 2 diabetes [1] and Alzheimer’s disease [2–4]. IDE also has
been implicated in regulating cellular ubiquitin levels [5],
natriuretic peptide-mediated signaling [6], and as a receptor for
Varicella-Zoster Virus [7].
There have been several recent structures of IDE [8–11] or
cysteine-free IDE in which serine residues replace cysteine residues
[12–14] either alone or in complex with substrates [8–14]. These
structures show that IDE is composed of four structurally similar
domains with two each in the N- and C-terminal halves of the
molecule (IDE-N and IDE-C) [10,11]. In the structures obtained
to date, the enzyme exists in a closed conformation in which the
two halves of the molecule interact extensively and in which bound
substrates are trapped within a large enclosed cavity. In order for
catalysis to occur the enzyme must adopt an open conformation to
bind substrates and to release products, much like a clam opening
and closing. Although no IDE structure in the open conformation
has been reported, insight into the open conformation comes from
the related bacterial enzyme pitrilysin whose structure has been
solved in an open form (Protein Data Bank entry 1Q2L).
Tang and coworkers showed that disrupting several hydrogen
bonds that were presumed to help stabilize the closed conforma-
tion increased the rate of hydrolysis by IDE suggesting that the
transition from the closed to open conformation is rate-limiting
[10]. However, the finding that different substrates exhibit
different kcat values requires that either substrate/product identity
affects the rate of opening or that substrate cleavage in itself is rate
limiting. This follows since if the conformational change that
causes opening of the enzyme were solely rate limiting and
substrate-independent, all IDE substrates would exhibit the same
kcat, and this is clearly not the case [15].
In addition to the catalytic site, IDE contains a distal or exo site,
which can bind the distal portion of extended substrates [9,10].
Small peptides can also bind to this site, allosterically activating
IDE [9]. Additionally there is an activation site on the inner
surface of the C-terminal half of the molecule that binds
polyanions including ATP [8]. With small synthetic substrates,
occupation of this polyanion site increases rates fifty to a hundred
fold [16].
Several studies have used the cysteine-free form of IDE to study
aspects of IDE biology [12–15,17]. When we generated rat
cysteine-free IDE we found that catalytic activity was decreased
and that the ability to activate the enzyme by polyanions was
compromised. We report here a study on the role of cysteine
residues in the activity and polyanion activation of IDE and
identify cysteine 904 and its probable interacting partner
asparagine 575 as key residues required for maximal IDE activity
and polyanion activation.
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Materials and Methods
Materials
Tris(2-carboxyethyl)phosphine (TCEP) was obtained from
Hampton Research Corp. Abz-GGFLRKHGQ-EDDnp was
prepared as previously described [18]. A‹ ‹|4 was purchased from
AnaSpec, while insulin was from Sigma Chem. Co.
Preparation of IDE and its mutant variants
IDE and its mutant forms were expressed in 200 ml cultures of
Sf9 insect cells as previously described [8]. The enzyme was
purified by HIS-select Ni-NTA agarose (Sigma) affinity chroma-
tography. Typically enzyme of greater than 90% purity, as judged
by Coomassie staining of SDS-PAGE gels, was obtained, see
Figure S1 for representative gels. Mutations were introduced into
IDE using the QuickChange mutagenesis kit (Stratagene). For
generating cysteine-free IDE we made cysteine substitutions in
three cassettes in which individual cysteines were mutated to
serines and then the mutated portions of the cDNAs were cloned
back into the pFast Bac expression vector using appropriate
restriction sites. We also generated single point mutants in which
each of the 12 cysteines were converted to serines or where
Asn575 was changed to Leu or Thr, or Cys 904 was changed to
Ala. In each case we used pFast Bac HTb-IDE as the template. All
mutations were confirmed by DNA sequencing (Eurofins MWG
Operon).
Enzyme Assays
The fluorogenic peptide Abz-GGFLRKHGQ-EDDnp at
10 mM in 50 mM Tris-HCl buffer, pH 7.4 was used for routine
measurements of IDE activity as previously described [16].
Cleavage of this peptide by IDE occurs at the RK bond relieving
fluorescence quenching between the aminobenzyl (Abz) and
dinitrophenyl (EDDnp) groups. The reaction was monitored
continuously using a SpectraMax Gemini XS fluorescence plate
reader at an excitation of 318 nm and an emission of 419 nm.
Graphpad software was used to fit kinetic data to either a
hyperbolic substrate versus velocity response curve or to a
sigmoidal response curve.
With A‹ ‹|41–40 or insulin as substrate the reaction was measured
by following the disappearance of the substrate peak by HPLC.
Reaction mixtures containing 50 mM Tris-HCl buffer, pH 7.4,
10 mM A‹ ‹|41–40 or 10 mM insulin and enzyme in a total volume of
100 ml were incubated at 37uC for 0.5 or 1 hr. The reaction was
stopped by the addition of trifluoroacetic acid (TFA) to a final
concentration of 0.5%. The quenched reaction was applied to a
Vydac C4 HPLC column and an acetonitrile gradient developed
as previously described [16].
Analytical ultracentrifugation
Sedimentation velocity measurements were made at 4uC and
40,000 rpm, in a Beckman XL-A analytical ultracentrifuge
(Beckman, Fullerton, CA) with an An-60 Ti rotor. The sample
buffer contained 50 mM Tris, pH 7.4. Radial absorbance
distributions were recorded at 280 nm at 4 min intervals. Buffer
densities were measured with a Mettler densimeter; viscosities
were calculated from buffer composition using the program
SEDNTERP [19], available from http://www.rasmb.bbri.org/.
Sedimentation data were fit using a numerical solution of the
Lamm equation implemented in the program SEDFIT [19,20],
available from www.analyticalultracentrifugation.com. The result-
ing c(s,ff0) distributions were converted to standard 20,w
conditions using SEDNTERP [21].
Results
The rat IDE gene encodes a total of thirteen cysteine residues,
however the start site for translation is usually at the second
methionine in the sequence, which excludes the most N-terminally
encoded cysteine. Thus for this study we only considered the 12
cysteine residues in the predominantly expressed enzyme form,
Figure 1. When we generated a cysteine-free form of IDE by
converting these 12 cysteine residues in rat IDE to serine we found
an approximate 50% decrease in Vmax (51 mmols/min/mg for
wild type IDE compared to 23 mmols/min/mg cysteine-free IDE)
as well as a slight decrease in the Km for the substrate Abz–
GGFLRKHGQ-EDDnp (26 mM vs. 19 mM for wild type IDE and
cysteine-free IDE, respectively). There was essentially no change in
the Hill coefficient, Table 1 and Figure 2. This indicates that i)
no particular cysteine residue is required for activity, a finding in
agreement with those of others [12–15,17], but that one or more
cysteines are required for maximal activity and ii) a cysteine
residue is not required for the substrate induced cooperativity
characteristic of IDE with Abz-GGFLRKHGQ-EDDnp as
substrate.
When we examined the ability of a polyanion (ATP or TNP-
ATP) to increase the rate of Abz-GGFLRKHGQ-EDDnp
hydrolysis, we found that the cysteine-free enzyme was activated
to a considerably lesser extent than the native enzyme. Figure 3
shows that the cysteine-free IDE exhibits a maximal ,20 fold
activation by ATP or TNP-ATP compared to an ,100 fold
increase in activity with wild type IDE. In addition the KA for
ATP activation was ,10 fold lower for the cysteine-free enzyme
(0.0660.01 mM) than for wild type IDE (0.6960.06 mM),
Table 2, while that for TNP-ATP was 0.0660.01 mM for
cysteine-free IDE compared to 0.6460.07 mM for IDE. Thus
although ATP binds to the cysteine-free enzyme as evidenced by
its ability to increase the reaction rate, one or more cysteine
residues are required to achieve maximal polyanion activation.
Figure 1. Ribbons representation of the IDE crystal structure.
The position of cysteine residues, and other key features of IDE are
indicated.
doi:10.1371/journal.pone.0046790.g001
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In order to determine if a cystine might be present in IDE that
affects its activity we tested the effect of the reducing agent Tris(2-
carboxyethyl)phosphine (TCEP). We saw no affect of TCEP on
activity or on the ability of ATP to activate the enzyme. As a
control we tested the effect of TCEP on cysteine-free IDE and as
expected did not observe a change in either activity or ATP
activation.
In an attempt to identify the cysteine residue required for
maximal activity and maximal polyanion activation, each of the 12
cysteine residues was individually converted to an isosteric serine
residue. Although the majority of these mutants behaved similarly
to wild type IDE in terms of their activity with 10 mM Abz-
GGFLRKHGQ-EDDnp as substrate and their ability to be
activated by ATP, Table 2, two mutants showed both a decreased
maximal activity and a reduced activation by ATP; IDE-C171S
and IDE-C904S. However, IDE-C171S expressed poorly and was
difficult to purify. To rule out a specific effect of the serine residue
we converted Cys171 and Cys904 to alanines. The IDE-C171A
mutant expressed well and exhibited wild type enzyme activity and
polyanion activation, so it was not further studied. However,
substituting an alanine at position 904 produced an enzyme form
that exhibited nearly the same properties as the cysteine-free
enzyme, namely reduced activity and reduced activation by ATP,
Table 2. IDE-C904A retained the allosteric properties of wild
type IDE exhibiting a Hill coefficient of 1.560.2 with Abz-
GGFLRKHGQ-EDDnp as substrate.
The KA for ATP binding to IDE-C904A was the same as that
obtained for wild type IDE, 0.6560.13 mM. This is in contrast to
the cysteine-free enzyme where the KA for ATP deceased by ,10
fold. Thus substitution of either Ala or Ser at position 904
produced an enzyme form that was a hybrid between the wild type
enzyme and the cysteine-free enzyme. Relative to wild type IDE,
IDE-C904A/S exhibits reduced catalytic activity and reduced
activation by ATP, but the increase in ATP affinity seen for the
cysteine-free enzyme is not observed in this variant, Figure 4.
Thus a different serine or combination of serines must be
responsible for increasing the affinity of the enzyme for ATP.
We therefore measured ATP activation curves for each of the
cysteine to serine mutants and found that no one mutant exhibited
the low KA seen for the cysteine-free enzyme, Table 2. As shown
in Table 2 several Cys to Ser mutations caused a modest decrease
in the KA for ATP, but not of the magnitude seen in cysteine-free
IDE. These were C110 (KA - 0.35 mM), C171 (KA - 0.40 mM),
C178 (KA - 0.20 mM), C414 (KA - 0.27 mM), and C966 (KA -
0.34 mM). C110, C171, and C178 are clustered near the top of
the domain 1 active site, while C414 is also near the distal part of
the substrate binding site. C966 is in a disordered external loop not
seen in the crystal structure. In order to determine if multiple
cysteine residues could contribute to the binding of ATP we tested
a previously generated mutant in which C110, C171, and C178
were converted to serines. This mutant showed a lower KA for
ATP (0.11 mM), than any of the individual mutations, suggesting
that these and likely the other serines noted above produce small
structural changes that together increase the affinity for ATP.
In order to understand the possible consequences of mutating
C904 we examined its environment in the published x-ray
structures of rat and human IDE [8,10]. Although C904 is in
position to form a disulfide bond with C573, this was ruled out as
noted above by demonstrating an absence of any effect on activity
when the enzyme was treated with the reducing agent TCEP. In
addition mutating C573 to serine did not produce a significant
effect. However, Cys904 is also in position to form a hydrogen
bond with Asn575, Figure 5. We thus mutated Asn575 to Leu
and Thr and looked at the effect of these mutations on activity.
Interestingly both the N575T and N575L IDE mutants behaved
similar to the C904S/A mutants. The Vmax for these mutants was
decreased,7 to 30 fold relative to wild type IDE, Figure 6, while
activation by ATP or TNP-ATP was reduced from the 100 fold
seen with wild type IDE to ,20 fold, similar to that seen in
C904S/A. With the N575T and N575L mutants the KA for ATP
was essentially the same as for wild type IDE (,0.6 mM), not the
10 fold lower value characteristic of the cysteine-free enzyme.
To extend this analysis we examined the activity of cysteine-free
IDE with amyloid beta peptide 1–40 (Aß1–40) as a substrate. When
cysteine-free IDE was incubated with Aß1–40 with the same
amount of enzyme and for the same time, no detectable hydrolysis
was observed (Figure S2, middle panel). Thus the amount of
enzyme was increased to obtain a quantifiable rate (right panel
Figure S2). This analysis showed that in contrast to the ,2 fold
reduction in activity seen with the fluorogenic peptide, the activity
of cysteine-free IDE was decreased more than 20 fold with Aß1–40
as substrate, Table 3. This reduction in activity was recapitulated
Figure 2. Comparison of the kinetics of IDE to cysteine-free
IDE. Reactions of 200 ml contained 50 mM Tris-HCl buffer, pH 7.4, Abz-
GGFLRKHGQ-EDDnp at the indicated concentrations and 1 mg of IDE
(closed circles) or 2 mg of cysteine-free IDE (closed squares). The
cleavage of the Abz fluorogenic substrate was determined as described
in Methods. A higher amount of cysteine-free enzyme was used in order
to achieve similar reaction rates between IDE and cysteine-free IDE.
Shown are representative data from experiments that were conducted
with two different enzyme preparations.
doi:10.1371/journal.pone.0046790.g002
Table 1. Comparison of the kinetic properties of IDE and cysteine-free IDE with Abz-GGFLRKHGQ-EDDnp as substrate.
Enzyme form Specific Activity (nmols/min/mg) Hill Coefficient Km (mM)
IDE 50.668 1.660.2 26.164
Cysteine-free IDE 28.364 1.860.3 18.662
Kinetic constants were determined by measuring rates at variable concentration of Abz-GGFLRKHGQ-EDDnp as substrate. Data were fit to the Hill equation.
doi:10.1371/journal.pone.0046790.t001
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in the C904S/A mutants as well as with the N575T and N575L
mutants, Table 3. As a control we tested two other cysteine to
serine mutations that had little effect on the activity towards the
fluorogenic substrate, C812S and C819S. As seen with the
fluorogenic substrate these control mutations exhibited activity
that was similar to the wild type enzyme.
This study was then extended to include insulin as a substrate.
Here again when tested with the same amount of enzyme and for
the same time, cysteine free IDE showed little hydrolysis IDE,
(Figure S2, lower middle panel). As with Aß1–40 as substrate
amount of cysteine-free IDE enzyme was increased to obtain a
quantifiable rate (lower right panel Figure S2). This analysis
showed that cysteine-free enzyme exhibited ,20% of wild type
IDE activity towards insulin, Table 3. As with the other substrates
tested the single mutation of C904S/A also produced a large
decrease in insulin degrading activity as did the N575T and
N575L mutants. A relatively small effect (30 to 50% reduction in
activity) was seen with the control mutations C812S and C819S, in
contrast to the 80% to greater than 99% reduction in activity seen
with the Cys904 or Asn575 mutations.
We next determined the oligomerization state of IDE, cysteine-
free IDE, and the IDE C904S mutant by sedimentation
equilibrium. As shown in Figure 7, wild type IDE showed
primarily the dimeric (9.3 s) form with small amounts of monomer
(5.8 s) and higher oligomers present. This pattern did not change
when the enzyme was treated with TCEP or the polyanion
activator PPPi, data not shown. Cysteine-free IDE shows an
increase in monomer content, but this change cannot account for
the large differences in activation relative to the wild type enzyme.
A smaller species (2.3 s) is also observed in the cysteine-free
Figure 3. Comparison of the activation of IDE to cysteine-free IDE by ATP and TNP-ATP. Reactions of 200 ml contained 50 mM Tris-HCl
buffer, pH 7.4, 10 mM Abz-GGFLRKHGQ-EDDnp and 1 mg of IDE (closed circles) or 2 mg cysteine-free IDE (closed squares) and the indicated amount of
ATP (left) or TNP-ATP (right). Relative activity is defined as the activity observed at the indicated ATP or TNP concentration relative to the activity in
their absence. A higher amount of cysteine-free enzyme was used as noted in Figure 2. Shown are representative data from experiments that were
repeated twice using different enzyme preparations.
doi:10.1371/journal.pone.0046790.g003
Table 2. Effect of converting individual cysteine residues to serine on IDE kinetics.
Enzyme form
Activity at 10 mM Abz
substrate. (nmols/min/mg)
Fold Activation
by 4 mM ATP
Fold Activation
by 4 mM PPPi
KA for ATP
activation (mM)
IDE 8.4 +1.1 9163 4063 690670
Cysteine-free 6.8+0.2 2360.1 11.060.3 76614
C110S 9.060.3 8262 3562 350640
C171S 0.360.01 761 560.1 4006116
C178S 12.860/01 6861 2460.4 19769
C257S 6.160.1 6662 3260.7 522654
C414S 8.860.8 5462 2161.7 270639
C573S 5.560.2 6064 2565.6 696698
C590S 4.460.2 6063 2261.6 7496114
C789S 5.260.4 7362 45610 738664
C812S 7.460.6 9964 48614 687681
C819S 6.860.3 8363 67611 726670
C904S 0.360.0 1361 660.2 7696143
C966S 6.460.4 8865 56610 337666
C904A 1.660.1 1561 761.2 6546127
The activity of IDE and its cysteine mutants was determined using a fixed concentration of 10 mM Abz–GGFLRKHGQ-EDDnp as substrate. KA was determined by varying
[ATP] at a fixed substrate concentration of 10 mM. Data is expressed as the mean plus or minus the standard deviation. Each value represents measurements made two
to four times.
doi:10.1371/journal.pone.0046790.t002
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preparation, and may represent a contaminant or breakdown
product. The C904S mutant, which has similar activity to the
cysteine-free iDE, does not exhibit the increase in monomer
content or the small contaminant. Both the cysteine-free and
Cysteine904Serine mutants show broadening of the dimer and
oligomer peaks suggesting a more rapid equilibrium between
monomer - dimer and higher oligomers.
Discussion
In this study we have examined the role of cysteine residues in
the activity and polyanion activation of IDE. We have shown that
although cysteine residues are not required for IDE function,
cysteine 904 is required to achieve maximal activity. The
importance of cysteine residues for maximal activity varies with
different substrates. With the small synthetic peptide Abz-
GGFLRKHGQ-EDDnp the conversion of cysteines to serines
decreases activity by about 2 fold, with insulin as substrate activity
is decreased five fold, while with Aß as substrate activity decreases
more than 20 fold. As noted in the introduction, there have been a
number of studies that utilized the cysteine-free form of IDE. The
results reported here suggest that the results obtained in those
studies must be interpreted cautiously, since this form of IDE does
not retain full catalytic activity.
In addition to the decrease in activity noted above, conversion
of cysteines to serines causes a ,10-fold decrease in the ability of
polyanions to activate the enzyme with Abz-GGFLRKHGQ-
EDDnp as substrate. Again mutation of cysteine 904 was primarily
responsible for this effect. Substitution of serines for all of the
cysteines increases the affinity of the enzyme for ATP. Substitution
of Cys904 alone does not recapitulate this affect, rather a group of
cysteines acting cooperatively appear to produce the decreased KA
for ATP. Since the group of cysteines that contribute to this effect
are more than 25 A˚ from the polyanion binding site, this suggests
that conformational differences contribute to the increased affinity
for ATP, rather than direct interactions with the polyanion.
Crystal structures of IDE show a possible hydrogen bond
between cysteine 904 and asparagine 575. The finding that
mutation of asparagine 575 to leucine or threonine mimicked the
effect of mutating cysteine 904 suggests that cysteine 904 and
asparagine 575 do indeed interact, likely through hydrogen
bonding. Less likely is that both residues play independent roles
in IDE activity. The loss of this hydrogen bond most likely alters
the conformation of the enzyme such that activity and polyanion
activation are suppressed, but not eliminated. In comparing the
structures of IDE [11] and cysteine-free IDE [13] no obvious
conformational differences are apparent. However, such confor-
mation differences in the cysteine-free enzyme may be unfavorable
in the crystal structure.
Figure 4. Comparison of the activation of IDE mutants by ATP.
Reaction mixtures were as described in Figure 3 with ATP varied as
indicated. Shown are cysteine-free IDE (2 mg - closed circles), IDE
Cys904Ser (8 mg - closed squares), and IDE Cys904Ala (2 mg - closed
triangles). The activity is plotted as the activity observed at the
indicated ATP concentration relative to the activity in the absence of
added ATP. Shown are representative data from experiments that were
replicated with different enzyme preparations.
doi:10.1371/journal.pone.0046790.g004
Figure 5. Structure of IDE showing the relative positions of
Cys904, Cys573, and Asn575. The N- and C-terminal halves of the
molecule are colored yellow and blue, respectively. Bound ATP is shown
in stick representation.
doi:10.1371/journal.pone.0046790.g005
Figure 6. Comparison of the kinetics of IDE to C904S/A and to
N575T/L. Reaction mixtures contained 50 mM Tris-HCl buffer, pH 7.4,
10 mM Abz-GGFLRKHGQ-EDDnp and either 1 mg of IDE (closed circles),
4 mg of IDE C904S (closed inverted triangle), 4 mg of IDE C904A (closed
diamonds), 5 mg of IDE N575T (closed squares), or 2 mg of IDE N575L
(closed triangles). The insert shows a comparison of the IDE mutants.
Shown are representative data from experiments that were replicated
with different enzyme preparations.
doi:10.1371/journal.pone.0046790.g006
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What we do see is a change in the distribution between
monomers and dimers between IDE, which is primarily dimeric,
and the cysteine-free form of IDE, which has a higher proportion
of monomer. This change in oligomeric state does not correlate
with changes in IDE activity since as much as a 20 fold decrease in
activity is seen with Aß as substrate with only an ,2 fold decrease
in dimer content. Additionally the C904S mutant is primarily a
dimer like wild type IDE, yet differs significantly in activity from
wild type IDE.
The data is consistent with a model in which disruption of the
interaction between cysteine 904 and asparagine 575 results in a
small conformational change between dimeric units. We hypoth-
esize that the conformation of the mutant dimer differs from that
of the wild type dimer and is inherently less active and less able to
be activated by polyanions.
Supporting Information
Figure S1 Analysis of IDE purity by SDS-PAGE. IDE and
its mutant forms were purified as described in Materials and
Methods and 2 mg of protein was analyzed by SDS-PAGE using
Coomassie staining to visualize the protein bands. Panel A. Wild
Type IDE, Panel B. Cysteine free IDE, Panel C. IDE-C904S.
Molecular weight standards are included the first lane in each
panel.
(TIF)
Figure S2 HPLC chromatograms showing the hydroly-
sis of Aß1–40 and insulin by wild type IDE and cysteine-
free IDE used to calculate reaction rates. Top. Hydrolysis
of Aß1–40. Reaction mixtures containing 10 mM Aß1–40 in 50 mM
Tris-HCl, pH 7.4, were incubated with the indicated amounts
wild type IDE (30 min incubation) or cysteine-free IDE (middle
panel 30 min) or right panel 60 min). Samples were then subjected
to HPLC as described in Materials and Methods and the activity
was calculated on the basis of the difference in peak height
between Aß1–40 alone (curve A) or Aß1–40 in the presence of
enzyme (curve B). Bottom, Hydrolysis insulin. Reaction mixtures
as above containing 10 mM insulin were reacted with the indicated
amounts of IDE or cysteine-free IDE for 60 min. Samples were
analyzed as noted above with activity was calculated on the basis
of the difference in peak height between insulin alone (curve A) or
insulin in the presence of enzyme (curve B).
(TIF)
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gel filtration prior to repeating the analysis.
doi:10.1371/journal.pone.0046790.g007
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